|
American Medical Association |
Integrating Equity Into Harm Event Data Collection and Tracking |
0.25 |
Yes |
12/12/2026 |
|
Clinical Care Options, LLC |
Interactive Case Challenge 1 – Key Decisions for Selection of Risperidone/Paliperidone Formulations in a Patient Transitioning From Inpatient to Outpatient Care |
0.5 |
No |
10/17/2025 |
|
Clinical Care Options, LLC |
Interactive Case Challenge 2: LAI Treatment Options Including Aripiprazole for Bipolar I Disorder in an Outpatient Setting |
0.5 |
No |
10/22/2025 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Intermittent Auscultation Safety |
0.75 |
Yes |
11/7/2026 |
|
American Medical Association |
Is Consent for Chronic Care Management Required Regularly? |
0.25 |
Yes |
8/19/2027 |
|
American Medical Association |
Is Patient Authorization Required for Health Care Providers to Disclose PHI for Treatment Purposes? |
0.25 |
Yes |
5/2/2025 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Ischemic Stroke Fundamentals |
1 |
Yes |
12/8/2026 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Ischemic Stroke: Risk Issues for the Emergency Physician |
1 |
Yes |
12/14/2026 |
|
Clinical Care Options, LLC |
Iterative Psychopharmacology: How to Decide What to Do When First or Second Interventions Fail |
1 |
No |
12/31/2025 |
|
The Journal of Bone and Joint Surgery |
JBJS Clinical Classroom |
600 |
Yes |
12/31/2027 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Labor Induction-Module 1: Verdicts, Settlements, and a Case Study |
0.5 |
Yes |
8/21/2026 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Labor Induction-Module 2: Indications, Contraindications, ARRIVE Trial |
0.5 |
Yes |
8/21/2026 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Labor Induction-Module 3: Cervical Ripening |
0.5 |
Yes |
8/21/2026 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Labor Induction-Module 4: Mechanical Methods |
0.25 |
Yes |
8/21/2026 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Labor Induction-Module 5: Misoprostol |
0.5 |
Yes |
8/21/2026 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Labor Induction-Module 6: Oxytocin Pharmacodynamics |
0 |
Yes |
8/21/2026 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Labor Induction-Module 7: Oxytocin Safe Administration |
0.5 |
Yes |
8/21/2026 |
|
American Medical Association |
Less is More: Reducing Device Days and HAIs |
0.5 |
Yes |
6/25/2027 |
|
American Medical Association |
Leveraging Pharmacists to Get to Better Blood Pressure Control |
1 |
Yes |
7/25/2026 |
|
American Medical Association |
Leveraging Segmented Harm Event Data to Drive Equity Improvement |
0.25 |
Yes |
3/4/2026 |
